People on the Move
Medivir to roll in Christine Lind as CEO
Christine Lind has been appointed as the new CEO of Medivir AB, succeeding Niklas Prager.
Niklas will continue as CEO until April 1, from which Christine will take the reins.
Stockholm, Sweden-based Medivir is research and developing protease inhibitor design and nucleotide/nucleosides.
Christine has been Medivir's EVP Strategic Business Development since 2015, prior to which she was VP Business Development at LifeCell Corp. in New Jersey, US. Before this move into the pharma industry, she worked in healthcare investment banking.
